Abstract The family of resistin-like molecules (RELM), also known as found in inflammatory zone (FIZZ), consists of four members in mouse (RELMa/FIZZ1/HIMF, RELMb/FIZZ2, Resistin/FIZZ3, and RELMc/FIZZ4) and two members in human (resistin and RELMb). The importance of these proteins in many aspects of physiology and pathophysiology, especially inflammatory processes, is rapidly evolving in the literature, and many investigators are beginning to work in this field. Most published studies focus on only one isoform, do not evaluate other isoforms that might be present, and have not tested for the specificity of the antibody used. Because RELM isoforms have high sequence and structural similarity and both distinct and overlapping functions, it is important to use a specific antibody to distinguish each isoform in the study. We constructed and established HEK 293 cell lines that constitutively express each isoform. Using these cell lines, we determined the specificity of antibodies (both commercially available and laboratory-made) to each isoform by Western blot and immunofluorescence. Some of the antibodies showed specificity in Western blotting but were not applicable in immunofluorescence. Others showed cross reactivity in Western blot assays. Our results indicate that RELM antibody specificity should be taken into account when using them in research and interpreting data obtained with them.
Introduction
Proteins that comprise the resistin-like molecule (RELM) family are characterized by a unique cysteine-rich motif of C-X11-C-X8-C-X-C-X3-CX10-C-X-C-X-C-X9-C-C at the C-terminus (Banerjee and Lazar 2001; Chumakov et al. 2004; Kim et al. 2001; Steppan et al. 2001b ). To date, four isoforms of RELM have been identified in mouse and rat, and two have been identified in human. The nomenclature for this family of proteins is confusing because each member was discovered independently by separate, unrelated labs as a different functional protein, and each discovery led to a different name being assigned to the same protein family. Thus, each of the proteins has multiple names. They have been identified as ''found in inflammatory zone'' (FIZZ) in an airway reactivity model (Holcomb et al. 2000) , ''resistin'' and ''resistin-like molecule'' alpha, beta, and gamma (RELMa, RELMb, and RELMc) (Gerstmayer et al. 2003; Yang et al. 2003) , ''hypoxia-induced mitogenic factor (HIMF)'' in a model of pulmonary hypertension (Teng et al. 2003) , adipokines (resistin) (Steppan et al. 2001a, b) , insulin resistance proteins (ADSF) (Kim et al. 2001) , and as chemokines (XCP) (Chumakov et al. 2004) . The diverse nomenclature of the four murine and two human isoforms is shown in Table 1 . Throughout this article, we will refer to the isoforms as RELMa, RELMb, resistin, and RELMc.
Proteins in the RELM family have a secretory signal peptide at the N-terminus and a unique, fully conserved motif of 10 equally spaced cysteines at the C-terminus, which form five disulfide bonds. Both human and rodent variants contain between 105 and 114 amino acids, with notable interspecies (36-56 %) and intraspecies (37-72 %) homology (Table 2) , especially at the cysteine-rich C-terminus. Murine RELMc and RELMa have 72 % similarity in their amino acid sequence, the highest among all family members (Table 2) . RELMc and RELMb also have high similarity, especially at the C-terminus. In mouse, the genes of RELMa, b, and c are aligned sequentially on chromosome 16B5 as Retnlb, Retnla, and Retnlg; resistin is located separately on chromosome 8A1. In human, resistin is located on chromosome 19p13.2 and RELMb on chromosome 3q13.1.
Members of the RELM family were initially reported to have distinct tissue distribution (Chumakov et al. 2004; Gerstmayer et al. 2003; Holcomb et al. 2000; Steppan et al. 2001b) , and to some extent this holds true. However, this view is changing rapidly as more studies of RELM proteins are published. Under normal physiologic conditions, human resistin expression is seen predominantly in bone 
ADSF adipose tissue-specific secretory factor, FIZZ found in inflammatory zone, HIMF hypoxia-induced mitogenic factor, RELM resistinlike molecule, XCP ten-cysteine protein marrow, monocytes, and leukocytes, whereas human RELMb is found primarily in colon and small intestine and to a lesser extent in testis and spleen (Chumakov et al. 2004; Nohira et al. 2004) . Under normal conditions in mouse, RELMa expresses predominantly in lung, bone marrow, and spleen (Holcomb et al. 2000; Liu et al. 2004; Steppan et al. 2001b; Teng et al. 2002) ; RELMb expresses in intestinal epithelial cells (Artis et al. 2004; He et al. 2003; Steppan et al. 2001b) ; resistin expresses in white adipose tissue (Holcomb et al. 2000; Steppan et al. 2001a) ; and RELMc expresses in hematopoietic tissues and lung (Chumakov et al. 2004; Gerstmayer et al. 2003) . Exceptions to these initial findings have been found, particularly under pathophysiologic conditions and during development, and more are likely to be discovered. For example, both human resistin and RELMb have been reported to be present in the lungs of humans with asthma and scleroderma (Angelini et al. 2009; Homer 2007; Mishra et al. 2007 ). In the model of helminth-induced Th2-type immunity, murine (m) RELMa, mRELMb, and mRELMc expression was induced de novo in the lung and liver, where granulomas and inflammation formed after the mice were sensitized and challenged with S. mansoni eggs (Pesce et al. 2009 ). We have found RELMa, RELMb, and RELMc expression in rodent models of allergic inflammation and in chronic hypoxia models of pulmonary hypertension (unpublished observations). The study of RELM proteins in physiology and disease is now beginning to expand rapidly. As yet, little is known regarding the differences and similarities in function of the different isoforms. However, most studies of mouse or human RELM have focused on only one RELM isoform and have not evaluated expression of other isoforms in the same experiment. Furthermore, use of in situ hybridization to distinguish the isoforms in tissue is difficult because of the small size of the expressed sequence and the high homology between isoforms. Considering the high sequence similarity among RELM proteins and the growing evidence that multiple isoforms may be expressed within the same tissue, knowledge of antibody specificity is very important for evaluating the distinct expression and functions of each isoform. Excellent reviews have been published on the issue of antibody specificity, and researchers have offered suggestions on choosing an antibody and on appropriate use of controls when antibodies are used for immunohistology (Couchman 2009; Saper 2005) . However, the approach to antibody use is still a complex issue and can be especially difficult when one studies proteins that have a high degree of similarity, like those in the RELM family. To our knowledge, no one has tested available antibodies for specificity among the different RELM isoforms. Most companies that sell RELM antibodies or ELISA kits have not tested and do not report data for specificity. To help advance the field of RELM protein research, we used cells that express specific isoforms of RELM to test the specificity of RELM antibodies from multiple sources and to provide solid and comprehensive data that researchers can use to choose the most appropriate antibodies.
Methods

RELM-expressing cell lines
All RELM constructs that we used express fusion proteins that contain a FLAG tag at the C-terminus. We sequenced the DNA of all RELM constructs before transfection to confirm their nucleotide consistency with the NCBI database. In brief, we first inserted PCR products of RELM cDNAs into TOPO-TA vector (Invitrogen, Carlsbad, CA) and then added a FLAG tag sequence to the RELM sequence by inserting cDNAs into pFLAG-CMV 5.1 plasmid (Sigma) using designed restriction sites. Finally, using FLAG-tag primer, we constructed PCR products into pcDNA5/FRT/TOPO TA vector. The positive orientation of constructs was confirmed by sequencing. T-REx TM 293 cells (Invitrogen), a modified HEK 293 cell line that we used as host cells. Tetracycline (1 lg/ml) was used to induce expression of recombinant RELMs in the host cells, which were maintained in DMEM supplemented with 5 % fetal bovine serum, 2 mM glutamine, 100 U/ml penicillin, 100 lg/ml streptomycin, 100 lg/ml hygromycin B, and 5.0 lg/ml blasticidin.
Antibodies
Mouse anti-FLAG antibody was obtained from Sigma. The RELM antibodies used in this study are from multiple sources. The details for each antibody are listed in Table 3 .
Western blots RELM-containing medium was collected 2 days after tetracycline induction. Because human (h) RELMb is not secreted, we lysed hRELMb-producing cells in RIPA buffer to obtain that isoform. Thirty microliters of cell culture medium (or 30 lg of hRELMb cell lysate) were mixed with Laemmli sample buffer (Laemmli 1970 ) with b-mercaptoethanol and heated for 5 min at 99°C for denaturation. After heating, the samples were subjected to electrophoresis in a 4-20 % polyacrylamide gel (BioRad, Hercules, CA). Protein was then electrophoretically transferred onto nitrocellulose membrane (BioRad). The membrane was probed with RELM antibody (1:1,000) or anti-FLAG (1:3,000, Sigma, St. Louis, MO). The blots were developed with enhanced chemiluminescence (Amersham, Piscataway, NJ) and exposed to X-ray film (Denville Scientific, Metuchen, NJ).
Immunohistochemistry RELM-expressing HEK 293 cells grown on glass coverslips were induced overnight with tetracycline and then fixed with 4 % paraformaldehyde for 10 min. After being washed twice with PBS, the cells were permeabilized with 0.2 % Triton X-100 in PBS and then blocked with 2 % BSA in PBS before being incubated with anti-RELM antibodies overnight at 4°C. To enhance antigenicity of the protein, in some experiments we treated cells with 0.5 % sodium dodecyl sulfate (SDS) before the blocking step, according to published methods (Robinson and Vandre 2001 2-mercaptoethonal for 3 h at room temperature followed by iodoacetic acid (Campbell et al. 1999 ) before subjecting them to the SDS treatment. Cy2-or Cy5-conjugated donkey anti-goat IgG and Cy5-conjugated donkey anti-rabbit IgG were used as secondary antibodies. Nuclei were stained with 50 ng/ml 4 0 ,6 0 -diamidine-2-phenylindole dilactate (DAPI) for 5 min. A Zeiss 510 Meta confocal microscope was used for the imaging. Antibodies to mouse RELM isoforms were tested in all four murine RELMexpressing HEK 293 cell lines, and antibodies to human RELM isoforms were tested in human RELM-expressing HEK 293 cell lines.
Results
mRELMa antibody
Goat anti-mRELMa from R&D Systems (Minneapolis, MN) specifically recognized mRELMa, but no other isoform, by both Western blot (Fig. 1a) and immunohistochemistry (Fig. 1c) . Rabbit anti-mRELMa made in our own laboratory also showed good specificity in Western blotting (Fig. 1b) .
mRELMb antibody
In addition to recognizing mRELMb, mRELMb antibodies from Peprotech Inc. and Affinity Bioreagents (ABR; Golden CO) also bound weakly to mRELMc when the antibodies were produced in rabbit using the full-length mRELMb protein as antigen (Fig. 2a, b ). An antibody (kindly provided by Dr. Gary Wu, University of Pennsylvania) produced using an epitope at the N-terminus after the signal peptide (He et al. 2003 ) specifically bound to mRELMb on Western blots (Fig. 2c) . When its specificity was tested in immunohistochemistry, mRELMb antibody from ABR recognized mRELMb as well as mRELMc (Fig. 2d) . To enhance antigenicity in immunohistochemistry, we treated the cells with 0.5 % SDS for 10 min after they were permeabilized with Triton X-100 and then carried out blocking and antibody incubation. We found that this treatment greatly increased the specificity of the mRELMb antibody provided by Dr. Wu (Fig. 2e) . Rabbit anti-mResistin antibody from LifeSpan Biosciences (Seattle, WA) specifically bound to mResistin on Western blots. It also recognized only mResistin by immunohistochemistry (Fig. 3) . Although LifeSpan Biosciences claims that this antibody can be used for hResistin, it barely recognized hResistin on Western blot, and it bound equally to hResistin and hRELMb in HEK 293 cells (data not shown). Therefore, this antibody should not be used in human studies of resistin.
mRELMc antibody
Of the isoforms, mRELMc has highest homology to mRELMa (72 %), so identifying a unique epitope to produce antibody is difficult. Anti-mRELMc from Alpha Diagnostic International (ADI; San Antonio, TX) produced in rabbit to an unknown peptide recognized both mRELMc and mRELMa on Western blots (Fig. 4a) . We produced mRELMc antibodies using two different epitopes. When the laboratory-made anti-mRELMc antibodies were used for Western blotting, one had good specificity for mRELMc, whereas the other also showed weak binding to mRELMb (Fig. 4b, c) . In the immunohistochemical assay, the latter antibody bound all of the mRELM isoforms (Fig. 4d) , and the former bound none (data not shown). However, after cells were treated with SDS, the antibody that had initially shown no binding, exhibited binding only to mRELMb protein (Fig. 4e ).
hResistin antibody
We tested two hResistin antibodies in our system. AntihResistin from Santa Cruz Biotechnology (Santa Cruz, CA) bound weakly to hResistin but recognized mRELMb better. Goat anti-hResistin from R&D Systems specifically recognized hResistin in both Western blots and immunohistochemistry. It recognized no other isoforms, including mouse isoforms (Fig. 5) .
hRELMb antibody When used for Western blotting, anti-hRELMb from Acris Antibodies (San Diego, CA), Adipogen (San Diego, CA), and Chemicon (Temecula, CA) each specifically recognized the target protein hRELMb (Fig. 6a, b) . However, when used for immunohistochemistry, only goat antihRELMb from Acris specifically bound to hRELMb in hRELMb-expressing HEK 293 cells (Fig. 6c) . Discussion and conclusion
DAPI
Our laboratory was one of the first to study RELM proteins, particularly mRELMa. While expanding our research interest into other RELM isoforms, we found that some antibodies cross reacted to other family members, a problem that would lead to misleading results if not taken into consideration. To draw attention to this problem, we have tested the specificity of a variety of commercially available antibodies and some antibodies that we produced ourselves. Not all antibodies that can be used for Western blotting can be effectively applied in immunohistochemistry because in Western blotting, the antibody binds to denatured linear protein, whereas in immunohistochemistry, the antibody must recognize a folded protein with tertiary structure. Therefore, we tested each antibody in both Western blot and immunohistochemical assays. Many companies that provide commercial RELM antibodies have not considered the specificity of their antibodies across isoforms and species. Therefore, investigators need to be very cautious when using available antibodies to study RELM effects or expression and when interpreting data related to RELM protein expression. For example, some mRELMb antibodies can recognize both mRELMb and mRELMc. Although the signal for mRELMc is weak, such antibodies cannot be used for immunoprecipitation. We hope that this brief technical report can guide researchers in choosing RELM antibodies for their studies. It is important to look for each of the RELM isoforms in any related study rather than a single isoform in isolation. Additionally, investigators should realize that the same or different cell type within a tissue may express different RELM isoforms. We encourage each investigator and manufacturer to evaluate the specificity of the RELM antibodies that they use in the context of their own work. 
